In this episode, we discussed artificial intelligence's role in stem cell therapies by diving into the work of Cellino, a start-up biotech led by Nabiha Saklayen (co-founder) and Marina Madrid (co-founder) and Matthias Wagner. Their patented technology could hold some of the answers to how AI can help automate the stem cell manufacturing process making future treatments more affordable, scalable and standardised.
Also, stick around to the end; you might even get a cheeky book recommendation.
You can find the video we were talking about on Youtube: https://www.youtube.com/watch?v=CmnCHDoyfX
Create your
podcast in
minutes
It is Free